Augmedit

Augmedit, founded in 2018, is at the forefront of revolutionizing neurosurgery with its innovative approach to surgical precision. Headquartered in The Netherlands, the company is entrenched in the Health Care and VR/AR industries, aiming to eliminate intraoperative uncertainty through its slogan: "Holographic Intelligence for Neurosurgery."

Augmedit's technology offers AI-driven anatomical insights without the burden of heavy hardware, making AR visualization accessible. Their solutions, LumiNE Lite and Lumine Elite, are notable for being fully FDA cleared and CE marked. With a strong scientific foundation validated by over 20 peer-reviewed publications and 2,000 clinical cases, Augmedit positions itself as a vital extension of surgical expertise.

The company last secured a €1.00M Seed Round investment on 01 November 2022 from Revere Partners. With a strategic vision for expanding its influence across all surgical therapies, Augmedit invites potential investors to join its mission of enhancing patient outcomes by reducing surgical complexity.